APLI — Appili Therapeutics Balance Sheet
0.000.00%
Last trade - 00:00- CA$4.24m
- CA$12.33m
- CA$0.83m
Annual balance sheet for Appili Therapeutics, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 10.5 | 16.1 | 6.66 | 2.47 | 0.094 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.313 | 1.69 | 1.39 | 0.421 | 1.17 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 11.1 | 18.3 | 8.24 | 3.12 | 1.46 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.063 | 0.055 | 0.042 | 0.015 | 0.03 |
| Total Assets | 11.2 | 18.3 | 8.28 | 3.13 | 1.49 |
| Payable / Accrued | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1.38 | 4.62 | 6.67 | 2.98 | 11.5 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 2.33 | 5.56 | 11.6 | 10.5 | 12.4 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 8.85 | 12.8 | -3.27 | -7.4 | -10.9 |
| Total Liabilities & Shareholders' Equity | 11.2 | 18.3 | 8.28 | 3.13 | 1.49 |
| Total Common Shares Outstanding |